All In MedTech

Device Trial Radar · NCT05292326

Safety and Efficiency of the PacePress to Prevent Hemorrhagic Complications in Patients Undergoing CIED Implantation.

Assessment of Safety and Efficiency of the Medical Device Called PacePress to Prevent Hemorrhagic Complications in Patients With High Bleeding Risk Undergoing CIED Implantation Procedures in an Open-label, Multi-Centre Clinical Trial.

Last checked: Nov 20, 2026Latest source record: Sep 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 122 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

122

Actual

Start

May 25, 2021

Primary completion

Mar 14, 2025

Study completion Mar 14, 2025

Sponsor

Lead sponsor
Medinice S.A.Not on our public-company list
Sponsor type
Industry
First posted
Mar 23, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PacePress medical device, by ensuring constant compression force and the ability to optimize it in the pocket area prevents/significantly reduces the risk of hemorrhagic complications, including but not limited to the operation pocket hematoma. By avoiding a strong localized compression and ensuring "covering compression" achieved by the appropriate distribution of compression forces on the entire implantation site area, with an automated compression force control, the risk of a pressure sore created in the compressed pocket area is reduced.

Conditions

  • Hemorrhagic Complications
  • Hematoma
  • Hemorrhage
  • Pathologic Processes

Interventions

  • PacePressDevice

    an electronically-controlled compression site which, thanks to a well-selected compression force, may contribute significantly to preventing hemorrhagic complications following electrotherapy procedures, including to increasing safety of CIED implantation procedures and accelerate wound healing significantly

  • standard compression bandDevice

    standard used compression band/sand bag

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of hematoma presenceTime frame: 7 (-0/+2) days after the procedure

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • I Cardiology Clinic, Medical University in Poznań

    Poznan, Poland

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.